CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.66%, Turnover Reaches HKD 6.9758 Million
Newtimespace News: As of 10:41 on July 14, CSOP Hang Seng Biotech ETF (03174.HK) stood at HKD 3.362, up 0.66%. The ETF opened at HKD 3.338, with the latest net asset value (NAV) at HKD 3.330, a premium of 0.30%, a turnover of approximately HKD 6.9758 million, and assets under management of approximately HKD 845 million.
CSOP Hang Seng Biotech ETF (03174.HK) closely tracks the Hang Seng Biotech Index. The index covers biotech companies listed in Hong Kong, focusing on pharmaceuticals, biotechnology, medical equipment, and other fields, capturing innovative growth opportunities in the Hong Kong biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 5.36% in Morning Trade, Latest NAV at HKD 3.249
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 2.34% in Morning Trade, Turnover at HKD 5.2392 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 4.74% in Morning Trade, AUM at HKD 847.00 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 4.14% in Afternoon Trade, AUM at HKD 808 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 5.70% in Morning Trade, Latest NAV at HKD 3.038